Kymera Therapeutics (KYMR) PT Raised to $120 at Oppenheimer
Tweet Send to a Friend
(Updated - December 9, 2025 6:10 AM EST)
Oppenheimer analyst Jeff Jones raised the price target on Kymera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jeff Jones raised the price target on Kymera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
